Delivery Order SPE2DB20D2104-SPE2DB23FV09Z
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,264.96 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,572.92 firm fixed price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,105.16 firm-fixed-price delivery order is for the supply of 500 units of 4 mg Ondansetron HCL tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,981.77 firm fixed-price delivery order is for the supply of 4,567,060 units of 4 mg Ondansetron HCL tablets, with a completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,990.87 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The contract has an ultimate completion date of December 4, 2024 and was awarded on December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $62,997.07 Firm Fixed Price Delivery Order is for the supply of 4 mg Ondansetron HCL tablets in quantities of 500's. The contract has an ultimate completion date of April 21, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,077.14 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets to support military healthcare programs. The contract has a November 2024 completion date and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,418.29 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,146.74 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,898.97 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV09ZDelivery Order
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,685.69 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC includes critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition. The ultimate completion date for this specific delivery order is August 30, 2023.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/29/23 |